Tango Therapeutics: 'Hold' On Combination Strategy Shift Of Vopimetostat
Erasca Inc ERAS
$11.24
▼ -3.15%
($-0.37)
Open
$11.63
Prev Close
$11.61
Day Range
$11.18 – $11.72
52W Range
$1.06 – $24.28
Market Cap
$3.50B
Beta
0.72
EPS (TTM)
$-0.93
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-07-15 |
| Shares Out. | 310,980,000 |
| Website | erasca.com/ ↗ |
| Phone | 18584656511 |
Erasca Inc is a publicly traded company under the ticker symbol ERAS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
17 analysts (2026-05-01)
📰 Latest News for ERAS
Erasca, Inc. (ERAS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Transcript : Erasca, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 03
Mizuho Maintains Outperform on Erasca, Lowers Price Target to $26
Erasca (NASDAQ:ERAS) Beats Q1 Estimates on Promising ERAS-0015 Data
Erasca: 'Hold' On Substantial RAS Targeting ERAS-0015 But With Two Key Risks
Erasca Q1 EPS $(0.60) Misses $(0.22) Estimate
Erasca Reports First Quarter 2026 Business Updates and Financial Results